← Back to contracts

Defining Protective IgGs to Food Allergy

US · IL National Institutes of Health (NIH) grant awarded #nih-1R01AI187292-01A1

Summary

This project aims to define the characteristics of peanut-specific IgG antibodies that are associated with successful oral immunotherapy (OIT) for peanut allergy, to understand why OIT works for some individuals and not others.

What they want

The research will systematically characterize peanut-specific IgG responses to OIT, focusing on IgG specificity, affinity, and titers, as well as the role of glycosylation in regulating antibody effector functions. It will test the central hypothesis that protective allergen-specific IgGs preferentially bind activating FcγRs. This involves defining IgG signatures from OIT associated with outcomes and determining requirements for protective IgG during food allergy, using a multi-disciplinary approach including biophysics, biochemistry, cellular and molecular immunology, and glycobiology, analyzing samples from clinical trials and testing IgGs in functional models of anaphylaxis.
Deliverables
  • Discovery of biomarkers for successful peanut OIT
  • Outline of requirements for IgG that protect from food allergy
Technical requirements
  • Biophysics
  • Biochemistry
  • Cellular and molecular immunology
  • Glycobiology
  • Analysis of clinical trial samples
  • Functional models of food-mediated anaphylaxis

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541714
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Defining Protective IgGs to Food Allergy
Onboard